Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market
Core Insights - Turn Therapeutics, a clinical-stage biotechnology company, is set to begin trading its common stock on the Nasdaq Global Market under the ticker symbol "TTRX" on October 8, 2025 [1] Company Overview - Turn Therapeutics focuses on developing therapies in dermatology, wound care, and anti-infective sectors [1]